Selected research
Industry Research
Bioassay and Potency Testing Industry Research Report 2026
Market perspective
The global Bioassay and Potency Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioassay and Potency Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioassay and Potency Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioassay and Potency Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioassay and Potency Testing include Eurofins, Vimta Labs Ltd., WaveCyte BioLabs, Reaction Biology, Charles River Laboratories, Intertek, Pacific BioLabs, FyoniBio and Svar Life Science, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioassay and Potency Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioassay and Potency Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioassay and Potency Testing Market by Company
Eurofins
Vimta Labs Ltd.
WaveCyte BioLabs
Reaction Biology
Charles River Laboratories
Intertek
Pacific BioLabs
FyoniBio
Svar Life Science
Solvias
Bioassay GmbH
Clean Cells
Bioassay and Potency Testing Segment by Type
In Vitro Assay
In Vivo Assay
Bioassay and Potency Testing Segment by Application
Drug Development
Scientific Research
Other
Bioassay and Potency Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioassay and Potency Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioassay and Potency Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioassay and Potency Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioassay and Potency Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro Assay
- In Vivo Assay
Applications
- Drug Development
- Scientific Research
- Other
Companies covered
- Eurofins
- Vimta Labs Ltd.
- WaveCyte BioLabs
- Reaction Biology
- Charles River Laboratories
- Intertek
- Pacific BioLabs
- FyoniBio
- Svar Life Science
- Solvias
- Bioassay GmbH
- Clean Cells
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioassay and Potency Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 In Vitro Assay
- 2.2.3 In Vivo Assay
- 2.3 Bioassay and Potency Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Development
- 2.3.3 Scientific Research
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Bioassay and Potency Testing Breakdown Data by Type
- 3.1 Global Bioassay and Potency Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Bioassay and Potency Testing Forecasted Market Size by Type (2027-2032)
4 Bioassay and Potency Testing Breakdown Data by Application
- 4.1 Global Bioassay and Potency Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Bioassay and Potency Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioassay and Potency Testing Market Perspective (2021-2032)
- 5.2 Global Bioassay and Potency Testing Growth Trends by Region
- 5.2.1 Global Bioassay and Potency Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioassay and Potency Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Bioassay and Potency Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Bioassay and Potency Testing Market Dynamics
- 5.3.1 Bioassay and Potency Testing Industry Trends
- 5.3.2 Bioassay and Potency Testing Market Drivers
- 5.3.3 Bioassay and Potency Testing Market Challenges
- 5.3.4 Bioassay and Potency Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioassay and Potency Testing Players by Revenue
- 6.1.1 Global Top Bioassay and Potency Testing Players by Revenue (2021-2026)
- 6.1.2 Global Bioassay and Potency Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioassay and Potency Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioassay and Potency Testing Head Office and Area Served
- 6.4 Global Bioassay and Potency Testing Players, Product Type & Application
- 6.5 Global Bioassay and Potency Testing Manufacturers Established Date
- 6.6 Global Bioassay and Potency Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioassay and Potency Testing Market Size (2021-2032)
- 7.2 North America Bioassay and Potency Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioassay and Potency Testing Market Size by Country (2021-2026)
- 7.4 North America Bioassay and Potency Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioassay and Potency Testing Market Size (2021-2032)
- 8.2 Europe Bioassay and Potency Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioassay and Potency Testing Market Size by Country (2021-2026)
- 8.4 Europe Bioassay and Potency Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioassay and Potency Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Bioassay and Potency Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioassay and Potency Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioassay and Potency Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioassay and Potency Testing Market Size (2021-2032)
- 10.2 South America Bioassay and Potency Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioassay and Potency Testing Market Size by Country (2021-2026)
- 10.4 South America Bioassay and Potency Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioassay and Potency Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Bioassay and Potency Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioassay and Potency Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioassay and Potency Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins
- 12.1.1 Eurofins Company Information
- 12.1.2 Eurofins Business Overview
- 12.1.3 Eurofins Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.1.4 Eurofins Bioassay and Potency Testing Product Portfolio
- 12.1.5 Eurofins Recent Developments
- 12.2 Vimta Labs Ltd.
- 12.2.1 Vimta Labs Ltd. Company Information
- 12.2.2 Vimta Labs Ltd. Business Overview
- 12.2.3 Vimta Labs Ltd. Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.2.4 Vimta Labs Ltd. Bioassay and Potency Testing Product Portfolio
- 12.2.5 Vimta Labs Ltd. Recent Developments
- 12.3 WaveCyte BioLabs
- 12.3.1 WaveCyte BioLabs Company Information
- 12.3.2 WaveCyte BioLabs Business Overview
- 12.3.3 WaveCyte BioLabs Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.3.4 WaveCyte BioLabs Bioassay and Potency Testing Product Portfolio
- 12.3.5 WaveCyte BioLabs Recent Developments
- 12.4 Reaction Biology
- 12.4.1 Reaction Biology Company Information
- 12.4.2 Reaction Biology Business Overview
- 12.4.3 Reaction Biology Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.4.4 Reaction Biology Bioassay and Potency Testing Product Portfolio
- 12.4.5 Reaction Biology Recent Developments
- 12.5 Charles River Laboratories
- 12.5.1 Charles River Laboratories Company Information
- 12.5.2 Charles River Laboratories Business Overview
- 12.5.3 Charles River Laboratories Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.5.4 Charles River Laboratories Bioassay and Potency Testing Product Portfolio
- 12.5.5 Charles River Laboratories Recent Developments
- 12.6 Intertek
- 12.6.1 Intertek Company Information
- 12.6.2 Intertek Business Overview
- 12.6.3 Intertek Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.6.4 Intertek Bioassay and Potency Testing Product Portfolio
- 12.6.5 Intertek Recent Developments
- 12.7 Pacific BioLabs
- 12.7.1 Pacific BioLabs Company Information
- 12.7.2 Pacific BioLabs Business Overview
- 12.7.3 Pacific BioLabs Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.7.4 Pacific BioLabs Bioassay and Potency Testing Product Portfolio
- 12.7.5 Pacific BioLabs Recent Developments
- 12.8 FyoniBio
- 12.8.1 FyoniBio Company Information
- 12.8.2 FyoniBio Business Overview
- 12.8.3 FyoniBio Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.8.4 FyoniBio Bioassay and Potency Testing Product Portfolio
- 12.8.5 FyoniBio Recent Developments
- 12.9 Svar Life Science
- 12.9.1 Svar Life Science Company Information
- 12.9.2 Svar Life Science Business Overview
- 12.9.3 Svar Life Science Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.9.4 Svar Life Science Bioassay and Potency Testing Product Portfolio
- 12.9.5 Svar Life Science Recent Developments
- 12.10 Solvias
- 12.10.1 Solvias Company Information
- 12.10.2 Solvias Business Overview
- 12.10.3 Solvias Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.10.4 Solvias Bioassay and Potency Testing Product Portfolio
- 12.10.5 Solvias Recent Developments
- 12.11 Bioassay GmbH
- 12.11.1 Bioassay GmbH Company Information
- 12.11.2 Bioassay GmbH Business Overview
- 12.11.3 Bioassay GmbH Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.11.4 Bioassay GmbH Bioassay and Potency Testing Product Portfolio
- 12.11.5 Bioassay GmbH Recent Developments
- 12.12 Clean Cells
- 12.12.1 Clean Cells Company Information
- 12.12.2 Clean Cells Business Overview
- 12.12.3 Clean Cells Revenue in Bioassay and Potency Testing Business (2021-2026)
- 12.12.4 Clean Cells Bioassay and Potency Testing Product Portfolio
- 12.12.5 Clean Cells Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst